Moreover, there are blood tests based on biomarkers that measure the body's immune response to infection, such as the Qiagen ...

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, the first market for the hair loss ...

The latter approval is seen as the lever that will finally push annual sales of the drug above the $1 billion threshold, ...

A dual GLP-1 and glucagon agonist developed by Altimmune has been shown to reduce drinking in people with alcohol use ...

A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...

As a result, professionals responsible for lab operations, facilities, engineering, and asset management are taking on a more strategic role in supporting scientific excellence while driving ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease focal segmental glomerulosclerosis (FSGS). The company's already ...

UK biotech Antiverse has raised $9.3 million to accelerate its drug discovery programmes, based on an AI-powered platform for designing antibody-based therapeutics. Cardiff, Wales-based Antiverse's ...

Recordati has received an unsolicited takeover offer from private equity group CVC Capital Partners that, if completed, would delist the pharma group from the Italian stock exchange. The €52-per-share ...

Scribe Therapeutics has become the latest biotech to list on the Nasdaq in the US, raising more than $155 million to advance ...